SN
Shankar Narang
About Shankar Narang
Data last updated:
Shankar Narang is a Ceo at New Delhi Centre For Sight Limited (since 2024), Additional Director at Mehta Eye Clinic Private Limited (since 2025) and Director at Irx Pharmaceuticals Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Life Sciences. The 5 current companies with reported revenue have a combined latest revenue of ₹618 Cr; the largest is New Delhi Centre For Sight Limited at ₹582 Cr (FY 2025). Earlier, Shankar Narang was a Whole-Time Director at Cryoviva Life Sciences Private Limited (2023–2024) and Director at Lineage Healthcare Limited (2023–2024) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 18 Nov 2024 | 2002 | ₹582 Cr (FY 2025) | Active | |
| Additional Director | 01 Aug 2025 | 1992 | ₹13.16 Cr (FY 2025) | Active | |
| Director | 28 Feb 2025 | 2020 | ₹11.77 Cr (FY 2025) | Active | |
| Director | 27 Feb 2025 | 2023 | ₹6.21 Cr (FY 2025) | Active | |
| Director | 10 Sep 2025 | 2017 | ₹4.43 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 05 Sep 2023 | 2022 | ₹23.70 Cr (FY 2025) | Active | |
| Director | 10 Oct 2023 | 2011 | ₹26.56 Cr (FY 2025) | Active | |
| Additional Director | 18 Oct 2022 | 2011 | ₹90.40 Cr (FY 2026) | Active | |
| Director | 24 Jan 2018 | 2017 | ₹161 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shankar Narang
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankar Narang
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankar Narang
Shankar Narang currently holds 5 directorships: New Delhi Centre For Sight Limited (Ceo, since 18 Nov 2024, revenue ₹582 Cr (FY 2025)); Mehta Eye Clinic Private Limited (Additional Director, since 01 Aug 2025, revenue ₹13.16 Cr (FY 2025)); Irx Pharmaceuticals Private Limited (Director, since 28 Feb 2025, revenue ₹11.77 Cr (FY 2025)); Centre For Sight Kakathiya Private Limited (Director, since 27 Feb 2025, revenue ₹6.21 Cr (FY 2025)); Challa Eye Care Private Limited (Director, since 10 Sep 2025, revenue ₹4.43 Cr (FY 2025)).
Shankar Narang was first appointed on 24 Jan 2018 as Director at Paras Healthcare (Ranchi) Private Limited. The most recent appointment on record is 10 Sep 2025 at Challa Eye Care Private Limited.
The 5 current companies of Shankar Narang that report revenue have a combined latest revenue of ₹618 Cr: New Delhi Centre For Sight Limited ₹582 Cr (FY 2025); Mehta Eye Clinic Private Limited ₹13.16 Cr (FY 2025); Irx Pharmaceuticals Private Limited ₹11.77 Cr (FY 2025); Centre For Sight Kakathiya Private Limited ₹6.21 Cr (FY 2025); Challa Eye Care Private Limited ₹4.43 Cr (FY 2025).
Shankar Narang held 4 earlier board appointments: Cryoviva Life Sciences Private Limited (Whole-Time Director, 05 Sep 2023 to 15 Nov 2024); Lineage Healthcare Limited (Director, 10 Oct 2023 to 15 Nov 2024); Plus Medicare Hospitals Private Limited (Additional Director, 18 Oct 2022 to 14 Feb 2023); Paras Healthcare (Ranchi) Private Limited (Director, 24 Jan 2018 to 14 Feb 2023).
The current boards of Shankar Narang's companies include Ajay Bakshi (New Delhi Centre For Sight Limited), Alka Sachdev (New Delhi Centre For Sight Limited), Gitansha Sachdev (New Delhi Centre For Sight Limited), Mahipal Singh Sachdev (New Delhi Centre For Sight Limited), Nakul Anand (New Delhi Centre For Sight Limited), Raghav Ramdev (New Delhi Centre For Sight Limited), among others.